Alpha-1 Antitrypsin Mitigates the Inhibition of Airway Epithelial Cell Repair by Neutrophil Elastase

被引:18
作者
Garratt, Luke W. [1 ,2 ]
Sutanto, Erika N. [2 ,5 ]
Ling, Kak-Ming [2 ]
Looi, Kevin [1 ]
Iosifidis, Thomas [1 ,3 ]
Martinovich, Kelly M. [2 ]
Shaw, Nicole C. [2 ]
Buckley, Alysia G. [2 ,4 ]
Kicic-Starcevich, Elizabeth [2 ,5 ]
Lannigan, Francis J. [1 ,6 ]
Knight, Darryl A. [7 ,8 ,9 ]
Stick, Stephen M. [1 ,2 ,3 ,5 ]
Kicic, Anthony [1 ,2 ,3 ,5 ]
机构
[1] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia
[2] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia
[3] Univ Western Australia, Ctr Cell Therapy & Regenerat Med, Perth, WA 6009, Australia
[4] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Perth, WA 6009, Australia
[5] Princess Margaret Hosp Children, Dept Resp Med, Perth, WA, Australia
[6] Notre Dame Univ, Sch Med, Perth, WA, Australia
[7] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia
[8] Hunter Med Res Inst, Prior Res Ctr Asthma & Resp Dis, Newcastle, NSW, Australia
[9] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada
[10] Murdoch Childrens Res Inst, Melbourne, Vic, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
neutrophil elastase; cystic fibrosis; primary cell culture; wound repair; alpha-1; antitrypsin; CYSTIC-FIBROSIS PATIENTS; YOUNG-CHILDREN; LUNG-DISEASE; MORPHOLOGICAL-CHANGES; GENE-EXPRESSION; CIGARETTE-SMOKE; WOUND REPAIR; IN-VITRO; INTERLEUKIN-8; INFLAMMATION;
D O I
10.1165/rcmb.2015-0074OC
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neutrophil elastase (NE) activity is associated with many destructive lung diseases and is a predictor for structural lung damage in early cystic fibrosis (CF), which suggests normal maintenance of airway epithelium is prevented by uninhibited NE. However, limited data exist on how the NE activity in airways of very young children with CF affects function of the epithelia. The aim of this study was to determine if NE activity could inhibit epithelial homeostasis and repair and whether any functional effect was reversible by antiprotease alpha-1 antitrypsin (alpha 1AT) treatment. Viability, inflammation, apoptosis, and proliferation were assessed in healthy non-CF and CF pediatric primary airway epithelial cells (pAEC(non-CF) and pAEC(CF), respectively) during exposure to physiologically relevant NE. The effect of NE activity on pAEC(CF) wound repair was also assessed. We report that viability after 48 hours was significantly decreased by 100 nM NE in pAEC(non-CF) and pAEC(CF) owing to rapid cellular detachment that was accompanied by inflammatory cytokine release. Furthermore, both phenotypes initiated an apoptotic response to 100 nM NE, whereas >= 50 nM NE activity significantly inhibited the proliferative capacity of cultures. Similar concentrations of NE also significantly inhibited wound repair of pAEC(CF), but this effect was reversed by the addition of alpha 1AT. Collectively, our results demonstrate free NE activity is deleterious for epithelial homeostasis and support the hypothesis that proteases in the airway contribute directly to CF structural lung disease. Our results also highlight the need to investigate antiprotease therapies in early CF disease in more detail.
引用
收藏
页码:341 / 349
页数:9
相关论文
共 50 条
  • [21] Sensitive and specific measurement of alpha-1 antitrypsin elastase inhibitory activity
    Weber, A.
    Engelmaier, A.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [22] Evaluation of Alpha-1 Antitrypsin Levels and SERPINA1 Gene Polymorphisms in Sickle Cell Disease
    Seixas Carvalho, Magda Oliveira
    Carvalho Santos Souza, Andre Luis
    Carvalho, Mauricio Batista
    Almeida Souza Pacheco, Ana Paula
    Rocha, Larissa Carneiro
    Lopes do Nascimento, Valma Maria
    Boas Figueiredo, Camylla Vilas
    Guarda, Caroline Conceicao
    Santiago, Rayra Pereira
    Adekile, Adekunle
    Goncalves, Marilda de Souza
    [J]. FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [23] PROTEOLYTIC INACTIVATION OF HUMAN ALPHA-1 ANTITRYPSIN BY HUMAN STROMELYSIN
    WINYARD, PG
    ZHANG, Z
    CHIDWICK, K
    BLAKE, DR
    CARRELL, RW
    MURPHY, G
    [J]. FEBS LETTERS, 1991, 279 (01): : 91 - 94
  • [24] Alpha-1 Antitrypsin Therapy for Autoimmune Disorders
    Song, Sihong
    [J]. CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2018, 5 (04): : 289 - 301
  • [25] Alpha-1 antitrypsin targeted neutrophil elastase protects against sepsis-induced inflammation and coagulation in mice via inhibiting neutrophil extracellular trap formation
    Cai, Minghui
    Deng, Jiaxing
    Wu, Shangjie
    Cao, Yang
    Chen, Hong
    Tang, Hao
    Zou, Chendan
    Zhu, Hui
    Qi, Lishuang
    [J]. LIFE SCIENCES, 2024, 353
  • [26] Alpha-1 antitrypsin for cystic fibrosis complicated by severe cytokinemic COVID-19
    McElvaney, Oliver J.
    O'Connor, Eoin
    McEvoy, Natalie L.
    Fraughan, Daniel D.
    Clarke, Jennifer
    McElvaney, Oisin F.
    Gunaratnam, Cedric
    O'Rourke, James
    Curley, Gerard F.
    McElvaney, Noel G.
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (01) : 31 - 35
  • [27] Chymotrypsin-like Elastase-1 Mediates Progressive Emphysema in Alpha-1 Antitrypsin Deficiency
    Devine, Andrew J.
    Smith, Noah J.
    Joshi, Rashika
    Fan, Qiang
    Borchers, Michael T.
    Clair, Geremy C.
    Adkins, Joshua N.
    Varisco, Brian M.
    [J]. CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2023, 10 (04): : 380 - 391
  • [28] Alpha-1 Antitrypsin-A Target for MicroRNA-Based Therapeutic Development for Cystic Fibrosis
    Hunt, Alison M. D.
    Glasgow, Arlene M. A.
    Humphreys, Hilary
    Greene, Catherine M.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (03)
  • [29] A review of alpha-1 antitrypsin deficiency
    Ranes, J
    Stoller, JK
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 26 (02) : 154 - 166
  • [30] Alpha-1 Antitrypsin Deficiency and Pregnancy
    Gaeckle, Nate T.
    Stephenson, Laurel
    Reilkoff, Ronald A.
    [J]. COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 17 (03) : 326 - 332